Oscar Health Inc <OSCR.N>: Piper Sandler Raises Target Price to $36 from $26
OSCR•Related News
Abeona Therapeutics Q2 net loss widens, misses analyst expectations
ABEO•
Bit Digital Q2 Revenue USD 32.1 Million Vs. IBES Estimate USD 23.7 Million
BTBT•
Cocrystal Pharma Q2 FY26 net loss widens to $3.16 million; R&D expense climbs to $2.14 million
COCP•
Karyopharm Therapeutics Q2 Net Income USD -67.023 Million
KPTI•
Global markets-Stocks rise with oil price below $90, euro edges up, Iran in focus
SPY•